PLAC1 anticorps (C-Term)
Aperçu rapide pour PLAC1 anticorps (C-Term) (ABIN783753)
Antigène
Voir toutes PLAC1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody detects PLAC1 at C-term.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- 15 amino acid peptide near the carboxy terminus of human PLAC1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to three months or (in aliquots) at -20 °C for longer.
-
-
- PLAC1 (Placenta-Specific 1 (PLAC1))
-
Autre désignation
- PLAC1
-
Sujet
- PLAC1 was initially identified as a protein expressed specifically in the placenta and other cells derived from the trophoblast lineage during embryonic development, but has also been found to be expressed ectopically in a wide range of human malignancies, particularly breast cancers. PLAC1 is a membrane-associated protein that is thought to serve a receptor-like function modulating cell-cell or ligand receptor interactions unique to the maternal-placental interface. Decreased expression of PLAC1 is associated with decreased expression of cyclin D1 and reduced expression of AKT kinase, which, combined with the fact that PLAC1 is expressed on the surface of cancer cells, suggests that PLAC1 may be an effective candidate for immunotherapeutic treatments of cancer.Synonyms: Placenta-specific protein 1
-
ID gène
- 10761
-
NCBI Accession
- NP_068568
-
UniProt
- Q9HBJ0
Antigène
-